Serum high-sensitivity C-reactive protein, amyloid-associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia

Baskurt, M.; Akturk, F.; Keskin, K.; Canbolat, P.; Karadag, B.; Kaya, Gizem; Yildiz, A.; Coskun, U.; Kilickesmez, K.; Esen, O.; Muniboglu, S.

doi:10.5830/cvja-2010-041

Serum high-sensitivity C-reactive protein, amyloid-associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia

Copy For Citation

Baskurt M., Akturk F., Keskin K., Canbolat P., Karadag B., Kaya G., ...More

CARDIOVASCULAR JOURNAL OF AFRICA, vol.22, no.2, pp.85-89, 2011 (SCI-Expanded)

Publication Type: Article / Article
Volume: 22 Issue: 2
Publication Date: 2011
Doi Number: 10.5830/cvja-2010-041
Journal Name: CARDIOVASCULAR JOURNAL OF AFRICA
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.85-89
Istanbul University Affiliated: Yes

Abstract

Aim: The aim of this study was to detect any relationship between serum high-sensitivity C-reactive protein (hs-CRP), serum amyloid-associated protein (SAA) and N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, and reversible myocardial ischaemia during cardiovascular exercise tests and to determine whether these biomarkers could predict transient myocardial ischaemia.